Trial Profile
Safety and efficacy trial of lacosamide as an adjunctive therapy in infants and young children with refractory focal epilepsy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Lacosamide (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Therapeutic Use
- 01 Dec 2015 New trial record